Richter SH, Schick A, Hoyer C, Lankisch K, Gass P, Vollmayr B.Cogn Affect Behav Neurosci. 2012 May 29. [Epub ahead of print] AbstractInvestigations of cognitive biases in animals are conceptually and translationally valuable because they contribute to animal welfare research and help to extend and refine our understanding of human emotional disorders, where biased information […]
Innamorati M, Pompili M, Martinotti G, Serafini G, Amore M, Lester D, Girardi P, Janiri L.Int J Soc Psychiatry. 2012 Apr 16. [Epub ahead of print] AbstractAIMS: To explore temporal trends since 1980 in alcohol-related death for people resident in the European Union (EU) and to examine differences between EU members admitted prior to 2004 […]
Geuze E, van Wingen GA, van Zuiden M, Rademaker AR, Vermetten E, Kavelaars A, Fernández G, Heijnen CJ.Psychoneuroendocrinology. 2012 Apr 11. [Epub ahead of print] AbstractINTRODUCTION: Individuals who are exposed to a traumatic event are at increased risk of developing psychiatric disorders such as posttraumatic stress disorder (PTSD). Studies have shown that increased amygdala activity […]
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD.Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. AbstractObjective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by […]
Sekiguchi A, Sugiura M, Taki Y, Kotozaki Y, Nouchi R, Takeuchi H, Araki T, Hanawa S, Nakagawa S, Miyauchi CM, Sakuma A, Kawashima R.Mol Psychiatry. 2012 May 22. doi: 10.1038/mp.2012.51. [Epub ahead of print] AbstractMany survivors of severe disasters, even those without posttraumatic stress disorder (PTSD), need psychological support. To understand the pathogenesis of PTSD […]
Golier JA, Caramanica K, Demaria R, Yehuda R.Depress Res Treat. 2012:393251. AbstractBackground. We obtained pilot data to examine the clinical and neuroendocrine effects of short-term mifepristone treatment in male veterans with PTSD. Methods. Eight male veterans with military-related PTSD completed a randomized, double-blind trial of one week of treatment with mifepristone (600 mg/day) or placebo. […]
Vermetten E, Lanius RA.Handb Clin Neurol. 2012;106:291-342. AbstractThree decades of posttraumatic stress disorder (PTSD) research have placed it well on the map. PTSD is a young disorder that started being properly understood only from 1980 with incorporation in DSM-III, in which it was acknowledged that exposure to traumatic events can lead to long-term psychopathology. This […]
Norredam M, Olsbjerg M, Petersen JH, Laursen B, Krasnik A.Inj Prev. 2012 May 24. [Epub ahead of print] AbstractBackground. The authors studied injury mortality in Denmark among refugees and immigrants compared with that among native Danes. Method. A register-based, historical prospective cohort design. All refugees (n=29,139) and family reunited immigrants (n=27,134) who between 1 January […]
Charlier P, Watier L, Ménétrier M, Chaillot PF, Brun L, Grandmaison GL.Med Hypotheses. 2012 May 22. [Epub ahead of print] AbstractDisturbances in some endocrine hormones have been implicated in the pathophysiology of depression and psychosis. We consider here further the hypothesis that there may be a correlation between suicide risk and the weight of the […]
Waters DD.Can J Cardiol. 2012 May 22. [Epub ahead of print] AbstractBiomarkers and imaging trials have often been used as guideposts in the development of drugs for atherosclerosis. This article explores the role of biomarkers and imaging trials in the development of 4 drugs: rimonabant, torcetrapib, ezetimibe, and niacin. Rimonabant, a selective cannabinoid-1 receptor, causes […]
